BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26962798)

  • 21. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
    Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
    Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study.
    Li QW; Zheng RL; Ling YH; Wang QX; Xiao WW; Zeng ZF; Fan W; Li LR; Gao YH
    Abdom Radiol (NY); 2016 Aug; 41(8):1448-55. PubMed ID: 27116012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined modality therapy for rectal cancer: the relative value of posttreatment versus pretreatment CEA as a prognostic marker for disease recurrence.
    Song S; Hong JC; McDonnell SE; Koong AC; Minsky BD; Chang DT; Liauw SL
    Ann Surg Oncol; 2012 Aug; 19(8):2471-6. PubMed ID: 22327251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinoembryonic antigen has prognostic value for tumor downstaging and recurrence in rectal cancer after preoperative chemoradiotherapy and curative surgery: A multi-institutional and case-matched control study of KROG 14-12.
    Lee JH; Kim DY; Kim SH; Cho HM; Shim BY; Kim TH; Kim SY; Baek JY; Oh JH; Nam TK; Yoon MS; Jeong JU; Kim K; Chie EK; Jang HS; Kim JS; Kim JH; Jeong BK
    Radiother Oncol; 2015 Aug; 116(2):202-8. PubMed ID: 26303015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 26. Defining and predicting early recurrence in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Zheng Z; Wang X; Huang Y; Lu X; Huang Z; Chi P
    Eur J Surg Oncol; 2020 Nov; 46(11):2057-2063. PubMed ID: 32782202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.
    Park YA; Sohn SK; Seong J; Baik SH; Lee KY; Kim NK; Cho CW
    J Surg Oncol; 2006 Feb; 93(2):145-50. PubMed ID: 16425302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endoscopic assessment of tumor regression after preoperative chemoradiotherapy as a prognostic marker in locally advanced rectal cancer.
    Sohn DK; Han KS; Kim BC; Hong CW; Chang HJ; Baek JY; Kim MJ; Park SC; Oh JH; Kim DY
    Surg Oncol; 2017 Dec; 26(4):453-459. PubMed ID: 29113665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Construction of a model based on multipoint full-layer puncture biopsy for predicting pathological complete response after neoadjuvant therapy for locally advanced rectal cancer].
    Jin Y; Zhai ZW; Sun LT; Xia PD; Hu H; Jiang CQ; Zhao BC; Qu H; Qian Q; Dai Y; Yao HW; Wang ZJ; Han JG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):403-411. PubMed ID: 38644246
    [No Abstract]   [Full Text] [Related]  

  • 30. Stage-to-stage comparison of preoperative and postoperative chemoradiotherapy for T3 mid or distal rectal cancer.
    Yeo SG; Kim DY; Park JW; Choi HS; Oh JH; Kim SY; Chang HJ; Kim TH; Sohn DK
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):856-62. PubMed ID: 21300482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of fibrinogen as a predictor in preoperative chemoradiation for rectal cancer.
    Lee JH; Hyun JH; Kim DY; Yoo BC; Park JW; Kim SY; Chang HJ; Kim BC; Kim TH; Oh JH; Sohn DK
    Ann Surg Oncol; 2015 Jan; 22(1):209-15. PubMed ID: 25384698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can normalized carcinoembryonic antigen following neoadjuvant chemoradiation predict tumour recurrence after curative resection for locally advanced rectal cancer?
    Hong Y; Ghuman A; Poh KS; Krizzuk D; Nagarajan A; Amarnath S; Nogueras JJ; Wexner SD; DaSilva G
    Colorectal Dis; 2021 Jun; 23(6):1346-1356. PubMed ID: 33570756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy.
    Moreno García V; Cejas P; Blanco Codesido M; Feliu Batlle J; de Castro Carpeño J; Belda-Iniesta C; Barriuso J; Sánchez JJ; Larrauri J; González-Barón M; Casado E
    Int J Colorectal Dis; 2009 Jul; 24(7):741-8. PubMed ID: 19259690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of Pathologic Complete Response in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation.
    Han YD; Kim WR; Park SW; Cho MS; Hur H; Min BS; Baik SH; Lee KY; Kim NK
    Medicine (Baltimore); 2015 Nov; 94(45):e1971. PubMed ID: 26559272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer.
    Yoo GS; Park HC; Yu JI; Choi DH; Cho WK; Park YS; Park JO; Lim HY; Kang WK; Lee WY; Kim HC; Yun SH; Cho YB; Park YA; Song KD; Kim SH; Ha SY
    Cancer Res Treat; 2020 Apr; 52(2):446-454. PubMed ID: 31588705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
    Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of Pathologic Complete Response After Neoadjuvant Treatment for Rectal Cancer: A Multicenter Study.
    Armstrong D; Raissouni S; Price Hiller J; Mercer J; Powell E; MacLean A; Jiang M; Doll C; Goodwin R; Batuyong E; Zhou K; Monzon JG; Tang PA; Heng DY; Cheung WY; Vickers MM
    Clin Colorectal Cancer; 2015 Dec; 14(4):291-5. PubMed ID: 26433487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of serial serum carcinoembryonic antigen values for treating rectal cancer with preoperative chemoradiotherapy.
    Ryu YJ; Kim CH; Kim HJ; Kang H; Lim SW; Huh JW; Ju JK; Kim YJ; Kim HR
    J Korean Soc Coloproctol; 2012 Aug; 28(4):205-12. PubMed ID: 22993707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
    Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
    J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of serum and tissue carcinoembryonic antigens for radiologic response and oncologic outcome of rectal cancer.
    Kim CH; Huh JW; Yeom SS; Kim HR; Kim YJ
    Pathol Res Pract; 2020 Mar; 216(3):152834. PubMed ID: 32001055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.